In contrast to activated T cells, preDSC-CM showed no significant effect on Jurkat cells, probably because of the much lower expression of CXCR3 by these tumor cells than by activated T cells (Supplementary Figure S1A). The gene discussed is CXCR3; the disease is neoplasm.